Sophiris Bio Inc (SPHS)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Randall E. Woods
Employees:
6
1258 PROSPECT STREET, LA JOLLA, CA, 92037
858-777-1760
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
-
Formally known as:
- PROTOX THERAPEUTICS INC. (TIER2)
Date | Ratio |
---|---|
2013-08-15 | 1:52 |
Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which develops products for the treatment of urological diseases. It is currently developing PRX302 as a treatment for the symptoms of benign prostatic hyperplasia which is a non cancerous enlargement of the prostate gland that causes a restriction in urine flow from the urethra resulting in lower urinary tract symptoms. The company was founded in May 2003 and is headquartered in La Jolla, CA.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|